Moreover, recent studies have demonstrated that activated signaling by the TGF-β superfamily, such as TGF-β, Nodal and Activin, increases the subpopulation of cancer stem cells in breast and pancreatic cancers [45], [46]. This evidence concerns the gene TGFB1 and pancreatic neoplasm.